Spine surgery is being reshaped less by any single technology than by a collision of forces: a federal payment system rewriting where operations happen, payers tightening what they will cover and a specialty under growing pressure to prove its results.
Some of those changes are visible in the operating room. Others are unfolding in reimbursement policy, insurer negotiations and the data increasingly used to determine who gets surgery in the first place. Together, they are redefining the future of spine care.
The following 10 trends are drawn from Becker’s coverage over the past year.
1. CMS is redrawing the site-of-service map while cutting the rates: In its 2026 outpatient and ASC rule, the agency added 573 codes to the ASC-covered procedures list and began phasing out the Medicare inpatient-only list, a three-year unwind that removes 285 mostly musculoskeletal procedures, 266 of them in 2026 alone. The 2027 proposed rule, released July 2, goes further: CMS proposed adding 618 codes and removing 637 procedures from the inpatient-only list.
Access is expanding and payment is not. The same proposed rule would cut four of the highest-volume pain management codes in ASCs, including radiofrequency ablation of lumbar facet joints from $948.66 to $908.27, despite an average 2.4% effective update across all ASC-covered procedures.
Wael Barsoum, MD, president and chief transformation officer at Phoenix-based Healthcare Outcomes Performance Co., pointed to “the elimination of the inpatient only list” as the year’s standout opportunity.
2. The site-of-service gap is still the number surgeons cannot unsee: For 2026, Medicare’s ASC conversion factor is $56.322 against $91.415 in the hospital outpatient setting, meaning an identical procedure has long paid one rate or another based on the address where it was performed. The 2027 proposal keeps the gap roughly intact at $57.766 and $102.004.
The evidence that the outpatient model works is accumulating. The first year of a bundled-payment program for outpatient spine surgery was associated with $1,201 in lower total episode spending and 2.2% fewer return inpatient admissions than at non-participating hospitals.
3. Payer friction is pushing surgeons out of network, and some out of insurance entirely: Brian Gantwerker, MD, a neurosurgeon at the Craniospinal Center of Los Angeles, described “new levels of dishonesty and clawbacks from the insurers,” warning it will push more physicians out of independence.
Some are exiting outright. One spine surgeon opened a practice that does not contract with commercial insurers or Medicare for clinic visits or surgeon fees, though patients can still use coverage for facility fees, anesthesia and imaging. On insurers denying endoscopic cases, he said: “There’s a wall in between us.”
4. Outcomes are becoming the currency, and the baseline is uncomfortable: Rod fracture rates run as high as 40% at five years in major deformity corrections, feeding a stubborn public perception that spine surgery leads to more spine surgery. Five-year reoperation rates for single-level lumbar discectomy reached 14.4% in a study published in Spine.
The practical exposure is referral risk. A program not capturing Oswestry Disability Index or PROMIS scores before surgery and at defined post-op intervals has no baseline to show a payer, and no way to prove a lower-cost outpatient fusion delivered an equivalent functional result.
5. AI is shifting from the scribe to the selection decision: Surgeons today operate with only about 30% of the estimated 150 variables believed to influence outcomes, and predictive modeling offers the clearest path to closing that gap.
D. Kojo Hamilton, MD, professor of neurological surgery at the University of Pittsburgh School of Medicine, described a move away from static radiographic targets toward patient-specific “digital twins.”
At Rothman Orthopaedics in Philadelphia, President Alex Vaccaro, MD, PhD, said ambient documentation will feed an AI patient selection platform analyzing everything from MRI imaging to wearable data.
6. Endoscopic technique is moving from niche to expectation: Tan Chen, MD, of Fairfax, Va.-based Inova, called the field’s current moment a “renaissance,” and named endoscopic and awake spine surgery as the two techniques most likely to stand out.
The data is following. Minimally invasive spine surgery was associated with reduced opioid consumption, with endoscopic procedures showing the lowest average use. The learning curve remains the barrier to adoption, and a systematic review in the March 2026 issue of The Spine Journal compared curves for uniportal and biportal techniques.
7. Motion preservation is becoming the first question, not the alternative: Scott Blumenthal, MD, of Plano, Texas-based Texas Back Institute, said the field will see “continued expansion of indications for motion preservation,” driven substantially by patients seeking an alternative to fusion.
The framing has flipped in some practices. Cervical arthroplasty is no longer positioned as an option for a small group of ideal patients; in one surgeon’s practice it is the starting point until instability, posterior compression or another anatomic finding makes fusion more appropriate.
8. Patient-specific implants are the near-term differentiator: CT-based preoperative planning now specifies cage size and the precise degree of correction, then builds the implant to the individual patient, mirroring a path total joint surgery followed years ago. Two-year data on Carlsmed’s aprevo implant showed reduced complication-related reoperations compared with conventional stock devices.
9. Bone health is moving from postoperative afterthought to surgical prerequisite: Roughly 25% to 30% of patients presenting for spine surgery have osteoporosis, according to the Spine Health Foundation, with many more showing osteopenia.
At Nashville, Tenn.-based Vanderbilt University Medical Center, spine surgeons partnered with rheumatology and endocrinology to treat bone quality before complex deformity surgery. Scott Zuckerman, MD, assistant professor of neurological surgery and orthopedic surgery, said that “once we started the Bone Optimization Clinic, our complications significantly decreased.”
10. The navigation argument has shifted from robots to what fits in a hand: Paul McAfee, MD, director of the Baltimore-based Scoliosis and Spine Center of Maryland, plans cases on an iPhone in a sterile mount costing roughly $1,200, using the same sensors that power consumer augmented reality. “The bulk of the surgery is done freehand,” he said of single- and two-level fusions.
The economics are the argument. A conventional spine robot rarely generates the case load to justify its price, and some hospitals never recoup the investment. Travis Doering, MD, an orthopedic surgeon in Austin, Texas, put it plainly on a panel at Becker’s 23rd annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference in Chicago June 11-13: “There still just really hasn’t been the literature to support widespread [robot] use.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.